Ligand Pharmaceuticals Incorporated Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$29.32 | $1.59 B | -7.1 | 60 | $0 |
ANNX
Annexon, Inc. |
$5.26 | $523.15 M | -3.93 | 71 | $0 |
APLS
Apellis Pharmaceuticals, Inc. |
$33.18 | $4.90 B | -11.77 | 702 | $396.59 M |
ASND
Ascendis Pharma A/S |
$136.38 | $7.77 B | -14.19 | 879 | $266.72 M |
BGNE
BeiGene, Ltd. |
$176.58 | $17.07 B | -20.76 | 10600 | $2.46 B |
BPMC
Blueprint Medicines Corporation |
$90.22 | $6.47 B | -21.48 | 638 | $249.38 M |
CGEM
Cullinan Oncology, Inc. |
$11.60 | $1.29 B | -7.16 | 85 | $0 |
CRNX
Crinetics Pharmaceuticals, Inc. |
$53.52 | $3.53 B | -11.86 | 290 | $4.01 M |
CYTK
Cytokinetics, Incorporated |
$48.91 | $6.05 B | -9.78 | 423 | $7.53 M |
DSGN
Design Therapeutics, Inc. |
$6.25 | $217.51 M | -3.7 | 54 | $0 |
ETNB
89bio, Inc. |
$7.94 | $796.91 M | -4.05 | 70 | $0 |
GPCR
Structure Therapeutics Inc. |
$27.92 | $2.47 B | -23.59 | 136 | $0 |
ICVX
Icosavax, Inc. |
$15.31 | $769.04 M | -6.96 | 60 | $582,000 |
LYEL
Lyell Immunopharma, Inc. |
$0.62 | $619.50 M | -2.7 | 224 | $130,000 |
ORIC
ORIC Pharmaceuticals, Inc. |
$8.21 | $595.34 M | -4.91 | 112 | $0 |
PASG
Passage Bio, Inc. |
$0.67 | $73.04 M | -0.77 | 58 | $0 |
RCUS
Arcus Biosciences, Inc. |
$15.51 | $1.41 B | -4.98 | 577 | $117.00 M |
RLAY
Relay Therapeutics, Inc. |
$4.17 | $1.05 B | -3 | 294 | $25.55 M |
TERN
Terns Pharmaceuticals, Inc. |
$5.87 | $462.44 M | -5.67 | 66 | $0 |
VRDN
Viridian Therapeutics, Inc. |
$19.03 | $776.72 M | -2.71 | 94 | $314,000 |